Elke Vereecke

Ms. Elke Vereecke


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2024 in Marine Drugs
Verified
Journal Article
Open access
PDF file
BCBert Coleman
Bert Coleman
EVElke Vereecke
Elke Vereecke
KLKatrijn Van Laere
Katrijn Van Laere
LNLucie Novoveska
Lucie Novoveska
JRJohan Robbens
Johan Robbens
Carotenoids, with their diverse biological activities and potential pharmaceutical applications, have garnered significant attention as essential nutraceuticals. Microalgae, as natural producers of these bioactive compounds, offer a promising avenue for sustainable and cost-effective carotenoid production. Despite the ability to cultivate microalgae for its high-value carotenoids with health benefits, only astaxanthin and β-carotene are produced on a commercial scale by Haematococcus pluvialis and Dunaliella salina, respectively. This review explores recent advancements in genetic engineering and cultivation strategies to enhance the production of lutein by microalgae. Techniques such as random mutagenesis, genetic engineering, including CRISPR technology and multi-omics approaches, are discussed in detail for their impact on improving lutein production. Innovative cultivation strategies are compared, highlighting their advantages and challenges. The paper concludes by identifying future research directions, challenges, and proposing strategies for the continued advancement of cost-effective and genetically engineered microalgal carotenoids for pharmaceutical applications.

15 December 2023
Verified
Book Chapter
Open access
PDF file
EVElke Vereecke
Elke Vereecke
KLKatrijn Van Laere
Katrijn Van Laere
TRTom Ruttink
Tom Ruttink
CRISPR/Cas is a gene-editing technique that allows for the precise and specific introduction of a mutation into a DNA sequence. The outcome of a mutation on encoded protein depends on the type of mutation (deletion, insertion and/or substitution) and the position of the mutation in the DNA sequence. It can be predicted by using screening methods that are able to identify a mutation at nucleotide level. Here, several screening methods are discussed with a difference in complexity, resolution and scalability and the results are interpretated by taken into account the central dogma of the molecular biology. Two modules of the SMAP package, SMAP haplotype-window and SMAP effect-prediction, are proposed and implemented in a high-throughput screening workflow that allows for the automated and streamlined screening of CRISPR experiments.